Session information

Symposium

[S41] Opening new frontier in development of RNA-based medicine by elucidation of defense mechanisms against exogenous RNAs

Sat. Mar 30, 2024 1:15 PM - 3:15 PM [Room 315] Conference Center 315 (3F)

Organizer: Shin-ich Hoshino (Grad. Sch. Pharm., Nagoya City Univ.), Nobuyoshi Akimitsu (ISC, Univ. Tokyo)

Since the 130th Annual Meeting of the Pharmaceutical Society of Japan held in Okayama in 2009, we have held a total of four RNA symposia. Over the course of the conference, we have transitioned to a focus on RNA drug discovery. Initially, the symposium mainly introduced basic research, over the course of the conference, we have transitioned to a strong focus on the development of RNA-based medicine. With the success of the mRNA vaccine against SARS-CoV-2, RNA-based medicine is now attracting a great deal of attention. Therefore, this year's RNA Symposium will introduce the latest research on RNA dynamics after viral and foreign RNAs introduced into cells. In addition, the latest findings on RNA modification and liquid-liquid phase separation, which play an important role in understanding the defense against foreign and viral RNAs, will be presented. In addition, RNA bioinformatics, which is now indispensable for RNA research, will be introduced to the members. The audience will understand various methodologies required for the development of RNA-based medicine.